Search results for "infarct"

showing 10 items of 1223 documents

Detection of Myocardial Infarction by Cardiac Magnetic Resonance in Embolic Stroke Related to First Diagnosed Atrial Fibrillation

2021

Elevated troponin levels are found in a significant number of patients who are diagnosed with acute embolic stroke (AES) after first diagnosed atrial fibrillation (AF). These myocardial injuries, which are known as cardiocerebral infarction (CCI), are potentially caused by coronary embolism and correspond to simultaneous cardiac and cerebral embolisms. However, this severe condition remains poorly understood. In this prospective study, we aimed to investigate the prevalence and the cardiac magnetic resonance (CMR) characteristics of CCI.Consecutive patients with first diagnosed AF hospitalized for AES in a neurovascular intensive care unit from 2019 to 2020 were included. Troponin Ic kineti…

Malemedicine.medical_specialtyComputed Tomography Angiographymedicine.medical_treatmentMyocardial InfarctionMagnetic Resonance Imaging CineInfarctionCoronary Angiographylaw.inventionElectrocardiography03 medical and health sciences0302 clinical medicinePredictive Value of TestslawInternal medicineAtrial FibrillationPrevalenceHumansMedicineProspective Studiescardiovascular diseasesMyocardial infarctionEmbolizationProspective cohort studyAgedAged 80 and overEmbolic Strokebiologybusiness.industryTroponin IRehabilitationAtrial fibrillationMiddle AgedNeurovascular bundlemedicine.diseaseIntensive care unitTroponinUp-Regulationbiology.proteinCardiologyFemaleSurgeryFranceNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessBiomarkers030217 neurology & neurosurgeryJournal of Stroke and Cerebrovascular Diseases
researchProduct

Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications.

2012

Objectives To investigate the premorbid use of secondary prevention medications in patients with recurrent vascular events. Design Prospective, observational, population based study. Setting The Dijon Stroke Registry and the registry of myocardial infarction of Dijon and Cote d9Or, France. Patients All patients with cerebral ischaemia (ischaemic stroke or transient ischaemic attacks) or coronary artery disease (CAD) and a history of vascular disease (cerebral ischaemia, CAD or peripheral arterial disease (PAD)) in Dijon, France from 2006 to 2010. Main outcome measures Data on medical history and prior use of treatments were collected. Mutivariate analyses were performed to identify predicto…

Malemedicine.medical_specialtyCoronary Artery DiseaseTransient ischaemic attacksBrain IschemiaCoronary artery diseasePeripheral Arterial DiseaseFibrinolytic AgentsRisk FactorsInternal medicinemedicineSecondary PreventionHumansMedical historycardiovascular diseasesMyocardial infarctionProspective StudiesRegistriesStrokeAntihypertensive AgentsAgedAged 80 and overVascular diseasebusiness.industryMiddle Agedmedicine.diseaseDrug UtilizationSurgeryPsychiatry and Mental healthRegimenSurgeryDrug Therapy CombinationFemaleNeurology (clinical)FranceHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessFibrinolytic agentJournal of neurology, neurosurgery, and psychiatry
researchProduct

Impact of Metabolic Syndrome on Atherosclerotic Burden and Cardiovascular Prognosis

2007

Patients with metabolic syndrome (MS) are at increased risk of cardiovascular atherosclerosis. The aim of this study was to evaluate the impact of MS on cardiovascular prognosis in context with atherosclerotic burden. A total of 811 patients with coronary heart disease (CHD) were included and carotid and leg arteries were examined using sonographic methods. Patients with low (CHD only, n = 428, 52.8%) or high atherosclerotic burden (CHD and peripheral atherosclerosis, n=383, 47.2%) were compared. Patients withor=3 of the following criteria: triglyceridesor=150 mg/dl, high-density lipoprotein cholesterol40 mg/dl (men) and50 mg/dl (women), body mass index30 kg/m2, blood pressureor=130/85 mm H…

Malemedicine.medical_specialtyCoronary DiseaseContext (language use)Internal medicinemedicineHumansProspective StudiesMyocardial infarctionStrokeAgedMetabolic SyndromeLegUltrasonography Doppler DuplexVascular diseasebusiness.industryHazard ratioMiddle AgedAtherosclerosisPrognosismedicine.diseaseCarotid ArteriesBlood pressureCirculatory systemCardiologyFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessThe American Journal of Cardiology
researchProduct

Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in Fra…

2020

Background The COVID-19 pandemic has had a profound effect on general health care. We aimed to evaluate the effect of a nationwide lockdown in France on admissions to hospital for acute myocardial infarction, by patient characteristics and regional prevalence of the pandemic. Methods In this registry study, we collected data from 21 centres participating in the ongoing French Cohort of Myocardial Infarction Evaluation (FRENCHIE) registry, which collects data from all patients admitted for ST segment elevation myocardial infarction (STEMI) or non-ST segment elevation myocardial infarction (NSTEMI) within 48 h of symptom onset. We analysed weekly hospital admissions over 8 weeks: the 4 weeks …

Malemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMyocardial InfarctionRate ratio01 natural sciencesCohort Studies03 medical and health sciencessymbols.namesake0302 clinical medicinePatient Admission[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk FactorsPrevalenceMedicineST segmentHumans030212 general & internal medicinePoisson regressionMyocardial infarctionRegistries0101 mathematicsPandemicsAgedAged 80 and overbusiness.industry010102 general mathematicsPublic Health Environmental and Occupational HealthCOVID-19ArticlesMiddle Agedmedicine.disease3. Good health[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieEmergency medicineCohortsymbolsObservational studyFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFrancebusinessCoronavirus InfectionsCohort study
researchProduct

Impact of symptomatic atherosclerosis in patients with pulmonary embolism

2019

Atherosclerosis is associated with increased cardiovascular mortality. Associations between venous thromboembolism and atherosclerosis were recently reported. We aimed to investigate the impact of symptomatic atherosclerosis on adverse outcomes in patients with pulmonary embolism (PE) and to identify significant differences among patients with PE stratified by symptomatic atherosclerosis.Patients were selected by screening the nationwide inpatients sample for PE (ICD-code I26) stratified by symptomatic atherosclerosis (composite of coronary artery disease [ICD-code I25], myocardial infarction [ICD-code I21], ischemic stroke [ICD-code I63], and/or atherosclerotic arterial diseases [ICD-code …

Malemedicine.medical_specialtyDeep vein030204 cardiovascular system & hematologyThrombophlebitisCoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansHospital Mortality030212 general & internal medicineMyocardial infarctionThrombusAgedAged 80 and overbusiness.industryAge FactorsMiddle AgedAtherosclerosismedicine.diseaseThrombosisPulmonary embolismmedicine.anatomical_structureHeart failureCardiologyFemalePulmonary EmbolismCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Impact of Systemic Atherosclerosis on Clinical Characteristics and Short-Term Outcomes in Patients with Deep Venous Thrombosis or Thrombophlebitis

2020

Venous thromboembolism (VTE) and atherosclerosis are accompanied by substantial cardiovascular mortality; links between both disease entities were reported. We aimed to investigate the impact of systemic atherosclerosis on adverse outcomes in patients with deep venous thrombosis or thrombophlebitis (DVT) and to identify differences in DVT patients with and without systemic atherosclerosis.The German nationwide inpatient sample was used for this analysis. Patients admitted for DVT were included in this study and stratified by systemic atherosclerosis (composite of coronary artery disease, myocardial infarction, ischemic stroke, and/or atherosclerotic arterial diseases). We compared DVT patie…

Malemedicine.medical_specialtyDiseaseThrombophlebitisCoronary artery diseaseRisk FactorsInternal medicinemedicineHumanscardiovascular diseasesMyocardial infarctionVenous Thrombosisbusiness.industryVenous ThromboembolismGeneral MedicineThrombophlebitisAtherosclerosismedicine.diseasePulmonary embolismVenous thrombosisConcomitantHeart failureCardiologyFemalePulmonary EmbolismbusinessThe American Journal of the Medical Sciences
researchProduct

Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry).

2002

There is conflicting information about gender differences in presentation, treatment, and outcome after acute ST elevation myocardial infarction (STEMI) in the era of thrombolytic therapy and primary percutaneous coronary intervention. From June 1994 to January 1997, we enrolled 6,067 consecutive patients with STEMI admitted to 54 hospitals in southwest Germany in the Maximal Individual TheRapy of Acute myocardial infarction (MITRA), a community-based registry. Women were 9 years older than men, more often had hypertension, diabetes mellitus, and congestive heart failure, and had a history of previous myocardial infarction less often. Women had a longer prehospital delay (45 minutes), had a…

Malemedicine.medical_specialtyEmergency Medical Servicesmedicine.medical_treatmentMyocardial InfarctionInfarctionAngina PectorisAnginaReperfusion therapySex FactorsInternal medicineGermanymedicineHumansThrombolytic TherapyMyocardial infarctionHospital MortalityProspective StudiesRegistriesAgedHeart Failurebusiness.industryPercutaneous coronary interventionThrombolysisOdds ratioMiddle Agedmedicine.diseaseSurvival AnalysisHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessThe American journal of cardiology
researchProduct

Sex-specific differences in mortality and the obesity paradox of patients with myocardial infarction ages70 y.

2017

Abstract Objectives Recent studies suggest an obesity survival paradox in patients with acute myocardial infarction (MI). The aim of this study was to investigate the in-hospital mortality of patients aged ≥70 y with acute MI relative to sex and obesity. Methods We selected patients ≥70 y of age with a diagnosis of acute MI based on the International Classification of Diseases (ICD) code I21 in the nationwide database of the Federal Statistical Office of Germany in 2014. We stratified the patients for sex and obesity versus nonobesity, and obesity classes I, II, and III. We compared the in-hospital mortality of these groups. Results In 2014, 122 607 patients ≥70 y of age were diagnosed with…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismMyocardial Infarction030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineSex FactorsInternal medicineGermanymedicineHumansIn patient030212 general & internal medicineMyocardial infarctionHospital MortalityObesityAgedNutrition and Dieteticsbusiness.industryMortality rateIncidence (epidemiology)Age FactorsRelative mortalitymedicine.diseaseObesitySex specificCardiologyFemalebusinessObesity paradoxNutrition (Burbank, Los Angeles County, Calif.)
researchProduct

Circulating endothelin-1 levels in type 2 diabetic patients with ischaemic heart disease.

1996

To investigate whether circulating endothelin-1 (Et-1) may be related to the increased incidence and severity of ischaemic heart disease in type 2 diabetes mellitus, we compared the concentrations in type 2 diabetic patients and in non-diabetic patients with coronary artery disease (CAD) angiographically documented. Plasma levels of Et-1 were determined in 34 type 2 diabetic patients with CAD (16 with stable angina, 6 with unstable angina, 12 with previous myocardial infarction) and in 19 nondiabetic patients with CAD (4 with stable angina, 5 with unstable angina, 10 with previous myocardial infarction). Fifteen diabetic patients without CAD and 9 healthy volunteers served as control subjec…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismMyocardial InfarctionMyocardial IschemiaBlood PressureAngina PectorisCoronary artery diseaseEndocrinologyReference ValuesDiabetes mellitusInternal medicineInternal MedicinemedicineHumanscardiovascular diseasesMyocardial infarctionEndothelial dysfunctionAgedAnalysis of VarianceEndothelin-1business.industryUnstable anginaIncidenceType 2 Diabetes MellitusGeneral MedicineMiddle Agedmedicine.diseaseEndothelin 1Diabetes Mellitus Type 2CardiologyFemaleComplicationbusinessActa diabetologica
researchProduct

Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction

2020

Diabetes mellitus (DM) represents a major cardiovascular risk factor for increased risk of coronary artery disease and myocardial infarction (MI). DM is also associated with a poorer clinical outcome in MI.The nationwide German inpatient population treated between 2005 and 2016 was used for statistical analyses. Hospitalized MI patients were stratified by the presence of DM and investigated for the impact of DM on in-hospital events.In total, 3,307,703 hospitalizations for acute MI (37.6% female patients, 56.8% aged ≥ 70 years) treated in Germany during 2005-2016 were included in this analysis. Of these patients, 410,737 (12.4%) died while in hospital. Overall, 1,007,326 (30.5%) MI cases we…

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationMyocardial Infarction030209 endocrinology & metabolism030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicineDiabetes MellitusInternal MedicinemedicineHumansHospital MortalityMyocardial infarctionRisk factoreducationAgededucation.field_of_studybusiness.industryMortality rateMetabolic disorderGeneral Medicinemedicine.diseaseTreatment OutcomeIncreased riskFemalebusinessDiabetes & Metabolism
researchProduct